The American Hospital Association has called on federal regulators to intervene after Eli Lilly sent warning letters to 340B hospitals threatening to cut off discounted drug pricing unless they submit ...

President Donald Trump has repeatedly vowed to “cut waste, fraud and abuse everywhere that we can find it.” Congressional ...

The American Hospital Association (AHA) writes to alert you to the latest development in connection with the growing number ...

The Health Resources and Services Administration should abandon its consideration of a 340B rebate model pilot program ...

When South Dakota’s Rep. Dusty Johnson (R-SD) speaks about expanding the federal 340B Drug Pricing Program, he does so with ...

Hospitals are not as unpopular as other health care sectors, such as drug manufacturers and insurance companies. But like other ...

Michigan's 340B Drug Pricing Program, meant to help vulnerable patients, is being misused by hospitals, impacting care access.

Hospitals and clinics told regulators that switching to rebates in the 340B drug discount program would impose costs that ...

In February 2026, the Department of Justice filed amicus briefs supporting pharmaceutical manufacturers, asserting that Rhode ...

LYNN– At a recent State House briefing hosted by the Massachusetts Health & Hospital Association, healthcare leaders gathered to discuss the future of the 340B Drug Pricing Program, a critical funding ...

AHA urges HRSA to axe 340B model that would cost hospitals over $1 billion annually and increase administrative burdens.

Tuesday’s bill gives powers to the Attorney General’s Office to further enforce state law that prohibits manufacturers from limiting access.